CAIRO3
Meta informatie
Publicatiedatum: 12-01-2018
Versie: 0.9
Ziektebeeld:  Maag-darmstelsel > Colon/Rectum
Fase:  Palliatief
Type:  Studie (pro)
Status:  Gesloten
Artikel code: D35
Auteur: admin

CAIRO3

Acties

Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab as first-line treatment in patients with advanced colorectal carcinoma, a randomised phase III study.